OptimizeRx Corporation (OPRX )

NASDAQ Capital Market Currency in USD Disclaimer

$7.15 +$0.87 (13.85%)

Closed 03/13/2025

Day's Range

$6.2

$7.83

52 wk Range

$3.78

$14.13

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Symbol OPRX
Company OptimizeRx Corporation
Price $7.15
Changes Percentage 13.85
Change 0.87
Day Low $6.2
Day High $7.83
Year High $14.13
Year Low $3.78
Market Cap $131,709,435
Price Avg 50 EMA (D) $5.45
Price Avg 200 EMA (D) $7.29
Exchange NASDAQ
Volume 2,414,670
Average Volume 492,467
Open $6.28
Previous Close $6.28
EPS -1.1
PE -6.50
Earnings Announcement 2025-05-12 20:00:00
Shares Outstanding $18,420,900

Company brief: OPTIMIZERX CORPORATION (OPRX )

Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Mr. William J. Febbo
Website https://www.optimizerx.com
Headquarters US
Employees (FY) N/A
Founded 11-28-2007
ISIN US68401U2042

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.